Evidence map›Paper›PMID 40715909›Full record

ReviewMolecular biology reports2025

A narrative overview of Staphylococcus haemolyticus: resistance traits, virulence factors, and health impact.

U Meenatchi, A Sridevi, A E Harish Vikas, Piyush Jagdish Balgote, Jayanthi Sivaraman

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. International journal of systematic and evolutionary microbiology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

U MeenatchiDepartment of Applied Microbiology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
A SrideviDepartment of Applied Microbiology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
A E Harish VikasDepartment of Applied Microbiology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
Piyush Jagdish BalgoteDepartment of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
Jayanthi SivaramanDepartment of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India. jayanthi.s@vit.ac.in.ORCID http://orcid.org/0000-0001-6722-1658

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Staphylococcus haemolyticus (S. haemolyticus) is a Gram-positive, facultative anaerobic bacterium emerging as a significant nosocomial pathogen, particularly in neonatal intensive care units. It primarily affects immunocompromised individuals and exhibits high levels of antibiotic resistance among coagulase-negative staphylococci (CoNS), underscores its global public health relevance. Advances in sequencing technologies have provided genomic insights into its pathogenicity, including biofilm formation and secretion of virulence factors. The organism is implicated in device-associated meningitis and neonatal central nervous system (CNS) infections. Current therapeutic challenges necessitate alternative treatment strategies, such as phage-derived endolysins and linezolid, especially when conventional options fail. This review outlines a comprehensive understanding of S. haemolyticus, focusing on its antibiotic resistance, virulence determinants, and the need for innovative approaches to combat healthcare-associated infections.

Indexed as

Drug Resistance, BacterialStaphylococcal InfectionsStaphylococcus haemolyticusVirulence FactorsAnti-Bacterial AgentsBiofilmsCross InfectionHumansVirulenceAnti-Bacterial AgentsVirulence FactorsAntibiotic resistanceBiofilmNosocomial infectionStaphylococcus haemolyticusVirulence factors

Identifiers

PMID40715909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.